Cholesterol for Interference Testing

• Description:

  Cholesterol for Interference Testing_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	K2010008H
  Lot number:	Batch Dependent
  Expiration date:	Batch Dependent
  Content:	Cholesterol 100 mg
  Appearance:	White Powder
  Application:	Interference Testing
  Shelf-Life	1 year
  Storage:	At -20°C.
  Keywords:	3β-Hydroxy-5-cholestene, 5-Cholesten-3β-ol , cholesterol interference

  _x000D_

  All Interference Products Brochure_x000D_

  _x000D_ _x000D_ _x000D_ References_x000D_

  _x000D_
  • Schiettecatte, J., Anckaert, E., and Smitz, J. (2012). Interferences in Immunoassays. Advances in Immunoassay Technology.
  _x000D_
  • Miller, J. J., and Levinson, S. S. (1996). Interferences In Immunoassays. Immunoassay, 165€“190.
  _x000D_
  • Ward, G. (2013). Rational investigations of immunoassay interferences. Pathology, 45.
  _x000D_
  • Park, J. Y., and Kricka, L. J. (2013). Interferences in Immunoassay. The Immunoassay Handbook, 403€“416.
  _x000D_
  • EP07: Interference Testing in Clinical Chemistry. (2020). Retrieved from https://clsi.org/standards/products/method-evaluation/documents/ep07/.
  _x000D_
  • Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 2020 Mar 5;9(3). pii: E629.
  _x000D_
  • Coussens NP, Auld D, Roby P, Walsh J, Baell JB, Kales S, Hadian K, Dahlin JL. Compound-Mediated Assay Interferences in Homogenous Proximity Assays. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-._x000D_ 2020 Feb 1.
  _x000D_
  • A new approach to overcome natural cholesterol interference during simultaneous determination of two stable isotope-enriched cholesterol tracers in human plasma. Wolff E, Vergnes MF, Kaloustian J, Abou L, Mikail C, Lairon D, Portugal H, Nicolay A. Rapid Commun Mass Spectrom. 2007;21(19):3175-9.
  _x000D_
  • The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Grafmeyer D, Bondon M, Manchon M, Levillain P. Eur J Clin Chem Clin Biochem. 1995 Jan;33(1):31-52.
  _x000D_
  • Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Stroke. 1995 Sep;26(9):1582-7.
  _x000D_

  _x000D_ Related Products_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-extra-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/hama-interference-kit-for-assay-validation/_x000D_ _x000D_  

• Short Description:

  Catalog #: K2010008H (100 mg)_x000D_ Cholesterol for Interference Testing is highly pure cholesterol provided as an amorphous white powder that can directly spiked into specimens to test Cholesterol interference in various assays. This product can also be used to make concentrated stock solutions of Cholesterol. Instructions are provided. Custom bulk orders of this product are available upon request.

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5